CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Hohenleitner Susan Chief Financial Officer | Sale | −1,558 | $3.86 | $6K | 227,520 |
| 2026-05-21 | Hohenleitner Susan Chief Financial Officer | Sale | −1,455 | $6.27 | $9K | 229,078 |
| 2026-02-20 | Hohenleitner Susan Chief Financial Officer | Sale | −1,786 | $5.87 | $10K | 230,780 |
| 2026-02-20 | Hohenleitner Susan Chief Financial Officer | Sale | −247 | $5.71 | $1K | 230,533 |
| 2026-01-23 | Hohenleitner Susan Chief Financial Officer | Grant or award | +85,670 | 232,566 | ||
| 2026-01-23 | Hohenleitner Susan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +128,505 | 128,505 |
Page 1 of 1 · 6 trades